Level Four Financial’s Pfizer PFE Stock Holding History

Level Four Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2K	Hold	2,000	–	–	﹤0.01%	297
2021 Q2	$1K	Buy	+2,000	New	+$77.8K	﹤0.01%	322

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Level Four Financial's PFE Position: Q3 2021 in Review

Level Four Financial increased its Pfizer (PFE) stake by 11% in Q3 2021, buying an estimated $98.6K and bringing the position to 23,060 shares worth $992K. The position accounts for 0.43% of the portfolio, ranked #58.

Level Four Financial first reported a position in PFE in Q4 2020 and has held it in 4 quarters since. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Level Four Financial held 23,060 shares of Pfizer worth $992K as of Q3 2021.
Level Four Financial bought 2,225 Pfizer shares in Q3 2021, an estimated $98.6K.
Pfizer made up 0.43% of Level Four Financial's portfolio in Q3 2021, its #58 holding.
Level Four Financial first reported a position in Pfizer in Q4 2020 and has held it in 4 quarters since.
2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.